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WHAT THIS PAPER ADDS
 The present study is the ﬁrst to investigate the potential of non-contrast-enhanced balanced turbo ﬁeld echo (bTFE) magnetic
resonance angiography (MRA) for depiction of upper extremity arteries and veins prior to vascular access creation, thereby enabling
the vascular surgeon to obtain detailed information about the upper extremity vascular tree without risking the induction of
nephrogenic systemic ﬁbrosis. Non-contrast-enhanced MRA image quality is lower regarding the arterial vascular tree, while
venous depiction is superior to contrast-enhanced MRA. Non-contrast-enhanced MRA is a feasible diagnostic modality in patients
with end-stage renal disease who need imaging of the upper extremity vasculature prior to dialysis access creationa r t i c l e i n f o
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Objectives: Preoperative mapping of arterial and venous anatomy helps to prevent postoperative
complications after vascular access creation. The use of gadolinium in contrast-enhanced (CE) magnetic
resonance angiography (MRA) has been linked to nephrogenic systemic ﬁbrosis in patients with end-
stage renal disease (ESRD). The purpose of this study was to evaluate non-contrast-enhanced (NCE)
MRA for assessment of upper extremity and central vasculature and to compare it with CE-MRA.
Methods: NCE and CE-MRA images were acquired in 10 healthy volunteers and 15 patients with ESRD. In
each data set, two observers analysed 11 arterial and 16 venous segments with regard to image quality
(0e4), presence of artefacts (0e2) and vessel-to-background ratio.
Results: More arterial segments were depicted using CE-MRA compared to NCE-MRA (99% vs. 96%,
p ¼ 0.001) with mean image quality of 3.80 vs. 2.68, (p < 0.001) and mean vessel-to-background ratio of
6.47 vs. 4.14 (p < 0.001). Ninety-one percent of the venous segments were portrayed using NCE-MRA vs.
80% using CE-MRA (p < 0.001). Mean image quality and vessel-to-background ratio were 2.41 vs. 2.21
(p ¼ 0.140) and 5.13 vs. 3.88 (p < 0.001), respectively.
Conclusions: Although arterial image quality and vessel-to-background ratios were lower, NCE-MRA is
considered a feasible alternative to CE-MRA in patients with ESRD who need imaging of the upper
extremity and central vasculature prior to dialysis access creation.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.The global patient population with end-stage renal disease
(ESRD) increases rapidly. Presently, the annual growth rate lies atþ31 43 3845473.
).
ciety for Vascular Surgery. Publisheabout 8%, resulting in an estimated 7.1 million patients depending
on renal replacement therapy by the year 2030.1,2 A substantial
number of these patients will be treated by haemodialysis (HD) for
which a functional vascular access (VA) is mandatory.
Guidelines of the National Kidney Foundation and the Vascular
Access Society as well as numerous clinical trials have emphasisedd by Elsevier Ltd. All rights reserved.
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prior to creation of a VA.3,4 However, despite preoperative ultra-
sound evaluation, the number of complications (non-maturation,
steal syndrome and cardiac failure) remains high.5 In an effort to
decrease these complications and improve long-term patency, the
‘patient-speciﬁc image-based computational modelling for
improvement of short- and long-term outcome of vascular access in
patients on haemodialysis therapy’ (ARCH) project consortium (7th
Framework European collaborative project) investigates alternative
preoperative imagingmodalities and develops predictivemodels to
aid clinical decision making,6 similar to those already used in other
ﬁelds of vascular surgery.7,8
Earlier studies of our group have established contrast-enhanced
magnetic resonance angiography (CE-MRA) to be of additional value
in the preoperative work-up of patients awaiting VA creation. For
instance, CE-MRA may identify arterial and venous stenoses not
detected by duplex ultrasonography (DUS), that are associated with
VA early failure and non-maturation.9 Furthermore, MRA enables
luminal diameter measurements over the entire arterial inﬂow and
venous outﬂow trajectory, including the central vessels. Therefore,
a more comprehensive assessment of upper extremity vasculature
can be performed, compared to selective diameter measurements
when using DUS. In addition, CE-MRA facilitates extraction of
complete upper extremity vascular geometry, which is desirable for
patient-speciﬁc modelling. However, recently it has become clear
that administration of gadolinium-based contrast agents (GBCAs) in
patients with ESRD may result in the development of nephrogenic
systemic ﬁbrosis (NSF),10,11 which is a potentially serious
complication.12
In an effort to preserve the potential diagnostic advantages of
preoperative MRA in patients with ESRD, we developed a non-
contrast enhanced (NCE) MRA technique for the upper extremity
based on a modiﬁed balanced turbo ﬁeld echo (bTFE) sequence
introduced by Gjesdal et al.13 The purpose of this study was to
assess the feasibility of this NCE-MRA technique and to compare
objective and subjective image quality with CE-MRA, which served
as the standard of reference.
Materials and Methods
The current study was performed as part of the ARCH project
(ICT-224390). For the complete clinical study protocol, the reader is
referred to Bode et al.6
Study population
For evaluation of upper extremity vasculature NCE-MRA was
compared to CE-MRA in 10 healthy subjects (ﬁve female, ﬁve male,Table 1
Sequence parameters of NCE-MRA and CE-MRA.
NCE-MRA
Central Proximal
Repetition time (ms) 4.5 5.6
Echo time (ms) 2.2 2.8
Flip angle (degrees) 90 90
Number of stacks 1 2
Field of view (mm) 300 175
Rectangular ﬁeld of view (%) 65 65
Matrix (scan/reconstruction) 244/384 224/512
Number of slices 125 120
Slice thickness (mm) 0.79 0.79
Acquired voxel size (mm) 1.34  0.84  0.78 0.78  0.78  0.79
Reconstructed voxel size (mm) 0.78  0.78  0.78 0.34  0.34  0.79
Scan duration (min) 4:45 5:48
Number of phases acquired 1 1mean age (SD): 26.2 (4.2) years) without any known cardio-
vascular disease or diabetes mellitus. After having established the
initial feasibility of the technique in the healthy subjects, 15
patients with ESRD (seven female, eightmale, mean age (SD): 61.5
(15.9) years, mean eGRF14 (SD): 9.3 (4.0) ml min1) awaiting
their ﬁrst VA creation were enrolled.
A random upper extremity was imaged in the healthy subjects
while in patients the extremity was chosen in which the preoper-
ative duplex examination was performed. The study was approved
by the local medical ethical committee. After explanation of the
potential risks and beneﬁts (including NSF), written informed
consent was obtained from all individuals and patients prior to
enrolment in the study.
MR imaging technique
All MR acquisitions were performed with a clinically available
1.5T MR scanner (Gyroscan Intera, software release 11.3.1, Philips
Medical Systems, Best, The Netherlands) using the Synergy
Flex-L surface coil for the distal upper extremity and the
Synergy Body coil for the proximal upper extremity and chest
acquisitions. The subject was put in a semi-oblique supine position
with an intravenous (IV) needle in the contralateral dorsum of
the hand.
The vasculature in the distal upper extremity was always
imaged ﬁrst, followed by the proximal upper extremity and the
chest. In each station, ﬁrst the NCE-MRA sequence was performed,
followed by the CE-MRA acquisition.
NCE-MRA
For NCE-MRA acquisitions, a modiﬁed version of the bTFE
sequence as described by Gjesdal et al. was used,13 which produces
images with increased signal from ﬂuid, analogous to T2-weighted
sequences, along with retaining T1-weighted tissue contrast.
Detailed image parameters are listed in Table 1.
CE-MRA
CE-MRA acquisition consisted of dynamic, multiphasic T1-
weighted gradient recalled echo sequences of the distal upper
extremity (ﬁrst acquisition), followed by the proximal upper
extremity and the chest (second acquisition). A macrocyclic
contrast agent (Gadovist, BayerSchering Pharma, Berlin, Germany),
for which no unconfounded cases of NSF have been reported in
patients with renal failure, was administered via a contralateral
intravenous cannula. Contrast medium was diluted using saline in
a 1:1 ratio (10 ml Gadovist and 10 ml saline) and administered in
two separate injections of 10 ml each for the distal and proximal
acquisitions, respectively.CE-MRA
Distal Proximal Distal
5.8 5.4 5.4
2.9 1.61 1.55
90 40 40
2 1 1
175 430 325
55 85 25
224/512 432/512 432/512
120 90 125
0.79 1.25 0.84
0.78  0.78  0.79 1.00  1.81  2.50 0.75  1.38  1.68
0.34  0.34  0.79 0.84  0.84  1.25 0.63  0.63  0.84
4:54 1:52 0:45
1 4 4
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on HD therapy were scheduled to undergo a complete 4-h dialysis
session directly after the MR acquisition, followed by regular dial-
ysis sessions 2 and 4 days later.15e17 The relevance of these
recommendations is underscored by the study of Prince et al.18 who
identiﬁed a decreased risk for the development of NSF in patients in
whom a non-macrocyclic GBCA was administered with an esti-
mated glomerular ﬁltration rate (eGFR) lower than 15mlmin1 and
who underwent post-procedural HD. All patients were monitored
for symptoms related to NSF at regular intervals: in HD patients,
a physical examination was performed every week, while pre-
dialysis patients were examined every 6 weeks during regular
follow-up of their residual renal function.Figure 1. Segmentation of the vascular tree for image analysis: The following segments wer
radial artery, ulnar artery, cephalic vein and basilic vein. In the proximal upper extremity and
the brachial artery, cephalic vein and basilic vein and proximal and distal segments of theMR image analysis protocol
The obtained data sets were reviewed by two experienced
radiologists (NP and TL with 8 and 15 years of experience in reading
cardiovascular MR images, respectively) in a blinded fashion. For
both NCE-MRA and CE-MRA, both reviewers evaluated all source
images and had the possibility to create maximum intensity
projections (MIPs) and multi-planar reformations (MPRs).
The upper extremity vascular tree was divided into 11 arterial
and 16 venous segments (Fig. 1), which were assessed for image
quality and artefacts as described in Table 2. In addition, vessel-to-
background contrast was calculated for the main arteries and veins
in the upper extremity by a single observer by measuring signale evaluated in the distal upper extremity: proximal, middle and distal segments of the
chest, the following segments were evaluated: proximal, middle and distal segments of
subclavian artery, cephalic vein and subclavian vein.
Table 2
Subjective parameters for image analysis.
Assessment Score
Image Quality Score 0: Not assessable; vessels not
visible or diagnostic information not obtained
Score 1: Poor; vessels visible but
suboptimally depicted due to incomplete
ﬁlling, blurring or other artefacts
Score 2: Moderate; vessels visible with low
signal intensity but the complete course
identiﬁable despite artefacts
Score 3: Good; vessels visible with high
signal intensity with minimal artefacts
Score 4: Excellent; vessels visible with
high signal intensity without artefacts
Artefacts Score 0: None
Flow artefacts Score 1: Minor artefacts, not hampering
image interpretation
Black-banding artefacts Score 2: Major artefacts hampering
image interpretation
Compression artefacts
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value by the standard deviation of signal intensity of muscle adja-
cent to the lumen.
Subsequently, the presence of stenoses and occlusions was
evaluated with both techniques. A ﬁve-point ordinal scale was used
for grading: 0 for 0e19% stenosis, 1 for 20e49% stenosis, 2 for
50e74% stenosis, 3 for 75e99% stenosis and 4 for occlusion.19 The
degree of stenosis was calculated by dividing the smallest in-plane
diameter of the vessel at the site of the stenosis by the diameter of
the closest normal-appearing vessel segment. A stenosis grade of
50% or more was considered haemodynamically signiﬁcant. The
potential of NCE-MRA for detection of stenosis was compared to
CE-MRA, which was used as the standard of reference.
Statistical analysis
The total number of visible segments as well as the mean
artefact score and vessel-to-background values in healthy volun-
teers and ESRD patients were compared using the non-parametric
McNemar and Wilcoxon signed ranks tests for paired samples.
Interobserver agreement regarding diagnostic image quality
(image quality  2) was assessed by the Cohen K test (K < 0 indi-
cating no agreement and 0e0.20 as slight, 0.21e0.40 as fair,
0.41e0.60 as moderate, 0.61e0.80 as substantial and 0.81e1 as
almost perfect agreement).20 In all statistical analyses, p values
<0.05 were considered to be statistically signiﬁcant. All statistical
analyses were performed using Statistical Package for the Social
Sciences (SPSS) 17.0.0 (SPSS Inc, Chicago, IL, USA) for Windows
(Microsoft, Redmond, WA, USA).Table 3A
Results in healthy volunteers (N ¼ 10).
Observer Arterial vascular t
NCE-MRA
Visible segments with image quality > 0 (%) 1 107/110 (97)
2 108/110 (98)
Image Quality (0e4) 1 3.19 (0.94)
2 3.38 (0.82)
Flow artefacts (0e2) 1 0.49 (0.80)
2 0.41 (0.60)
Magnetic ﬁeld inhomogeneities artefacts (0e2) 1 0.10 (0.39)
2 0.10 (0.30)
Compression artefacts (0e2) 1 0.01 (0.10)
2 0.00 (0.00)
Vessel-to-background ratio 4.55 (1.36)Results
All CE-MRA and NCE-MRA examinations were performed
successfully. No side effects after administration of GBCA were
noted. None of the patients developed any symptoms of NSF (mean
follow-up: 586  100 days).Healthy subjects
Results of objective and subjective image quality are listed in
Table 3A. Typical examples of CE-MRA and NCE-MRA acquisitions
are shown in Figs. 2 and 3. For the arterial vascular tree, CE-MRA
resulted in superior image quality and less artefacts due to ﬂow
or magnetic ﬁeld inhomogeneity, compared to NCE-MRA. In addi-
tion, CE-MRA resulted in a better vessel-to-background ratio when
compared to NCE-MRA. On the other hand, for the venous system,
NCE-MRA resulted in visualisation of more vessel segments, better
image quality and higher vessel-to-background ratio compared to
CE-MRA. However, NCE-MRA examinations were prone to more
ﬂow- and magnetic ﬁeld inhomogeneity artefacts. In healthy
volunteers, therewas moderate interobserver agreement regarding
the determination of diagnostic image quality in NCE-MRA and CE-
MRA sequences. Kappa values were 0.50 and 0.58, for NCE-MRA
and CE-MRA, respectively.Patients
In the ESRD patient population we found superior arterial
depiction with CE-MRA compared to NCE-MRA, as well as less
artefacts related to ﬂow or magnetic ﬁeld inhomogeneity. On the
other hand, more venous segments were visualised using NCE-
MRA. Image quality for veins was comparable with the two
sequences (Table 3B). Flow- and black-banding artefacts were not
present in the CE-MRA images. There was moderate interobserver
agreement regarding the determination of diagnostic image quality
in NCE-MRA (K ¼ 0.51) and a good interobserver agreement in CE-
MRA (K ¼ 0.64).
Blinded review of the CE-MRA and NCE-MRA data sets resulted
in the identiﬁcation of six low-grade stenoses (grade 0 and I) in the
subclavian artery (2), the radial artery (3) and the ulnar artery (1)
using CE-MRA, and three low-grade stenosis in the subclavian
artery (1) and the radial artery (2) with NCE-MRA. Two out of three
stenoses identiﬁed with NCE-MRA corresponded with CE-MRA
ﬁndings. In one case, irregularities in the subclavian artery as
seenwith NCE-MRAwere not seenwith CE-MRA. Conversely, at CE-
MRA four non-signiﬁcant stenoses were visualised which were
classiﬁed as normal with NCE-MRA. None of these stenoses were
depicted in the preoperative DUS examination.ree Venous vascular tree
CE-MRA P-value NCE-MRA CE-MRA P-value
110/110 (100) NA 150/155 (97) 125/155 (81) <0.001
110/110 (100) NA 150/155 (97) 131/155 (85) <0.001
3.99 (0.10) <0.001 2.86 (1.22) 2.44 (1.60) 0.003
3.95 (0.27) <0.001 2.90 (1.13) 2.14 (1.31) <0.001
0.11 (0.65) <0.001 0.49 (0.72) 0.13 (0.62) 0.002
0.07 (0.54) <0.001 0.43 (0.65) 0.16 (0.63) <0.001
0.00 (0.00) 0.009 0.20 (0.56) 0.00 (0.00) 0.004
0.00 (0.00) 0.001 0.31 (0.59) 0.00 (0.00) <0.001
0.00 (0.00) 0.317 0.23 (0.62) 0.33 (0.72) 0.380
0.00 (0.00) 1.000 0.28 (0.68) 0.32 (0.69) 0.083
6.01 (2.39) 0.001 5.41 (2.00) 4.53 (2.82) 0.012
Figure 2. Composite whole volume maximum intensity projection of typical NCE-MRA
acquisition with corresponding cross-sectional reformations; 1) central vessels, 2)
upper arm, 3e4) lower arm. Despite both arteries and veins being depicted in the NCE-
MRA data set, arteries and veins can easily be differentiated in the axial source images
because of the high spatial resolution. Note high signal intensity due to presence of
synovial ﬂuid.
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In this study, we found that upper extremity vasculature can be
depicted relatively adequately using bTFE NCE-MRA. Nevertheless,
with the described image protocol, CE-MRA remains superior in
terms of total number of visible arterial segments and overall image
quality. However, NCE-MRA was of diagnostic quality (image
quality  2) in the vast majority arterial segments (82%). For
depiction of venous structures, on the other hand, we found NCE-
MRA to be superior to dynamic CE-MRA because of the high
intrinsic vessel-to-background contrast, regardless of the presence
of contrast material.
In clinical routine, DUS is the method of choice in the preoper-
ative work-up of patients with ESRD. DUS is a highly valuable
imaging modality and its use has been associated with signiﬁcant
reductions in postoperative access-related complications.21,22
Nevertheless, postoperative access failure rates remain unaccept-
ably high,5 which has sparked the search for alternative techniques
of preoperative assessment. Prior work by our group found CE-MRA
to yield additional insights in vascular geometry, vascular dimen-
sions and the presence of pathology, particularly on locations
where DUS examination lacks diagnostic accuracy (e.g., the central
arteries and veins). Moreover, MRA enables time-efﬁcient interro-
gation of the entire upper extremity vascular tree, instead of just
several discrete locations. The present study was motivated
because there is a paucity of data on the clinical feasibility and
accuracy of novel NCE-MRA techniques for evaluation of upper
extremity vasculature.
Unlike the lower extremity, reports on NCE-MRA protocols for
depiction of upper extremity vasculature are scarce, particularly in
patients awaiting VA creation. Most of these publications deal with
either outdated NCE techniques suffering from major artefacts,
limited ﬁeld of views (FOVs) and long acquisition times.23e25
Although local venous anatomy could be identiﬁed, more prox-
imal and central vessels could not be depicted because of limited
surface coil coverage and difﬁculties in patient positioning.
The recently described lower extremity NCE-MRA protocol of
Gjesdal and collegues13 was adapted in such a way that it facilitated
depiction of the upper extremity vascular tree. Despite the excellent
results in the lowerextremities,we foundour sequence tobeproneto
artefacts, as was reﬂected in lower image quality and higher artefact
scores.Most likely, this is induced by theoff-centre positioningof the
upper extremity inside the bore of the MR, where magnetic ﬁeld
inhomogeneities are more pronounced.26 Nevertheless, diagnostic
images were obtained in the vast majority of subjects.
In the patient population, six low-grade stenoses (grade 0 and I)
were detected using CE-MRA compared to three low-grade stenoses
with NCE-MRA. In the three remaining cases, the narrowings were
not seen with NCE-MRA. Although these stenoses were not hae-
modynamically signiﬁcant, theywere not found in the preoperative
DUS examination, emphasising the potential additional value of
obtaining complete vascular geometry for diameter measurements
over the complete arterial and venous vascular tree. In this limited
sample, both MRA techniques excluded the presence of signiﬁcant
(>50% luminal narrowing) stenoses, thus conﬁrming ﬁndings at
DUS. The most likely explanation for the minor mismatches is the
better spatial resolution of theNCE-MRAdata, which is less prone to
partial volume effects. Our results reﬂect those of Gupta et al. who
found that bTFE is capable of accurately detecting stenoses.27
What is the potential additional value of MRA in clinical practice
considering the higher costs and lower availability in the era of
widespread DUS usage? With regard to the current results, we
hypothesise that routine preoperative assessment using the
described NCE-MRA sequence is potentially beneﬁcial in all
patients prior to dialysis access creation because vascular
Figure 3. Composite whole volume maximum intensity projection of typical CE-MRA acquisition in arterial phase (A) and venous phase (B) with corresponding cross-sectional
reformations.
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on, and non-invasive extraction of vascular geometry for patient-
speciﬁc computational modelling becomes feasible. Nonetheless,
until its clinical relevancy has been established in a large clinicalTable 3B
Results in ESRD patients (N ¼ 15).
Observer Arterial vascular
NCE-MRA
Visible segments with image quality > 0 (%) 1 157/165 (95)
2 154/165 (93)
Image Quality (0e4) 1 2.25 (0.97)
2 2.30 (1.12)
Flow artefacts (0e2) 1 0.34 (0.59)
2 0.31 (0.94)
Magnetic ﬁeld inhomogeneities artefacts (0e2) 1 0.59 (0.77)
2 0.59 (0.86)
Compression artefacts (0e2) 1 0.02 (0.13)
2 0.01 (0.16)
Vessel-to-background ratio 3.87 (3.67)trial, NCE-MRA should always be performed as a supplementary
examination to DUS and, therefore, will result in additional costs in
the preoperative work-up. To what extent these additional costs
may be compensated by a reduction in the management costs oftree Venous vascular tree
CE-MRA P-value NCE-MRA CE-MRA P-value
163/165 (99) 0.109 219/240 (91) 197/240 (82) <0.001
164/165 (99) 0.006 198/240 (83) 180/240 (75) 0.015
3.53 (0.69) <0.001 2.19 (1.16) 2.22 (1.40) 0.701
3.81 (0.55) <0.001 2.01 (1.35) 2.09 (1.53) 0.358
0.00 (0.00) <0.001 0.29 (0.54) 0.07 (0.34) <0.001
0.00 (0.00) <0.001 0.30 (0.57) 0.04 (0.24) <0.001
0.04 (0.19) <0.001 0.57 (0.80) 0.05 (0.25) <0.001
0.00 (0.00) <0.001 0.53 (0.84) 0.00 (0.00) <0.001
0.00 (0.00) 0.083 0.15 (0.48) 0.17 (0.54) 0.444
0.01 (0.08) 0.655 0.21 (0.59) 0.33 (0.72) 0.001
6.77 (3.56) <0.001 4.93 (3.20) 3.42 (1.47) <0.001
A.S. Bode et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 88e9494postoperative complications needs to be elucidated in further
studies. For that reason, one might argue to perform NCE-MRA only
in patients with a high probability of vascular pathology or post-
operative ﬁstula dysfunction (e.g., patients with marginal duplex
ﬁndings, patients with multiple previous failures or patients with
multiple previous CVC’s).
This study has limitations. First, we compared high spatial
resolution NCE-MRA images with slightly lower resolution CE-MRA
images. This discrepancy was unavoidable because both the arterial
and venous systems needed to be depicted with a limited dose of
non-bloodpool macrocyclic contrast agent. Because of the differ-
ence in voxel size between CE-MRA and NCE-MRA, we did not
compare vascular diameter measurements between the two tech-
niques. Nonetheless, we believe that NCE-MRA images can be used
for accurate appraisal of vascular diameters due to the high spatial
resolution, bearing in mind our prior study which found lower
spatial resolution CE-MRA diameter assessment to correspond
reasonably well with DUS assessment and intra-operative
measurements.28 Second, acquisition of distal, proximal and
central stations required repositioning of the patient usingmultiple
surface coils. Future work should be aimed at the ‘real world’ value
of an NCE-acquisition of the complete upper extremity, preferably
within a single acquisition using large coverage coils in combina-
tion with continuously moving table techniques.29 Furthermore,
there was no comparison with intra-arterial digital subtraction
angiography, which is the established reference standard with the
highest spatial resolution. Finally, we have not investigated the
impact of NCE-MRA on clinical outcome, but this was not the
objective of this study.
In conclusion, we have demonstrated that bTFE NCE-MRA is
a feasible alternative to CE-MRA for depiction of upper extremity
vasculature. NCE-MRA has the potential to also provide valuable
complementary information to CE-MRA. Future studies are needed
to investigate the value of NCE-MRA prior to VA creation and the
potential of patient-speciﬁc modelling using patient-speciﬁc
geometry obtained by NCE-MRA.
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